<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25419900</article-id><article-id pub-id-type="publisher-id">PONE-D-14-09900</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0113357</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Clinical Immunology</subject><subj-group><subject>Infectious Disease Immunology</subject></subj-group></subj-group><subj-group><subject>Classical Immunology</subject></subj-group></subj-group><subj-group><subject>Parasitology</subject><subj-group><subject>Parasite Groups</subject><subj-group><subject>Apicomplexa</subject><subj-group><subject>Plasmodium</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Biomarker Epidemiology</subject></subj-group></subj-group><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Serologically Defined Variations in Malaria Endemicity in Par&#x000e1; State, Brazil</article-title><alt-title alt-title-type="running-head">Malaria Endemicity in Brazil and Antibodies</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cunha</surname><given-names>Maristela G.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Eliane S.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sep&#x000fa;lveda</surname><given-names>Nuno</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Sheyla P. T.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Saboia</surname><given-names>Tiago C.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guerreiro</surname><given-names>Jo&#x000e3;o F.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000f3;voa</surname><given-names>Marinete M.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Corran</surname><given-names>Patrick H.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Riley</surname><given-names>Eleanor</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Drakeley</surname><given-names>Chris J.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas, Universidade Federal do Par&#x000e1;, Bel&#x000e9;m, Par&#x000e1;, Brazil</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Immunology and Infection, London School of Hygiene &#x00026; Tropical Medicine, London, United Kingdom</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Center of Statistics and Applications, University of Lisbon, Lisbon, Portugal</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Instituto Evandro Chagas, Ananindeua, Par&#x000e1;, Brazil</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Braga</surname><given-names>&#x000c9;rika Martins</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Universidade Federal de Minas Gerais, Brazil</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>mgcunha@ufpa.br</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: MGC CJD. Analyzed the data: MGC NS MMP ER CJD. Wrote the paper: MGC NS CJD. Organized the survey and collected samples: MGC JFG SPTC TCS. Performed the assays: MGC ESS PHC. Reviewed and approved the manuscript: MGC ESS NS SPTC TCS JFG MMP PHC ER CJD.</p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2014</year></pub-date><volume>9</volume><issue>11</issue><elocation-id>e113357</elocation-id><history><date date-type="received"><day>18</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>25</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 Cunha et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Cunha et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Measurement of malaria endemicity is typically based on vector or parasite measures. A complementary approach is the detection of parasite specific IgG antibodies. We determined the antibody levels and seroconversion rates to both <italic>P. vivax</italic> and <italic>P. falciparum</italic> merozoite antigens in individuals living in areas of varying <italic>P. vivax</italic> endemicity in Par&#x000e1; state, Brazilian Amazon region.</p></sec><sec><title>Methodology/Principal Findings</title><p>The prevalence of antibodies to recombinant antigens from <italic>P. vivax</italic> and <italic>P. falciparum</italic> was determined in 1,330 individuals. Cross sectional surveys were conducted in the north of Brazil in Anaj&#x000e1;s, Bel&#x000e9;m, Goian&#x000e9;sia do Par&#x000e1;, Jacareacanga, Itaituba, Trair&#x000e3;o, all in the Par&#x000e1; state, and Sucuriju, a free-malaria site in the neighboring state Amap&#x000e1;. Seroprevalence to any <italic>P. vivax</italic> antigens (MSP1 or AMA-1) was 52.5%, whereas 24.7% of the individuals were seropositive to any <italic>P. falciparum</italic> antigens (MSP1 or AMA-1). For <italic>P. vivax</italic> antigens, the seroconversion rates (SCR) ranged from 0.005 (Sucuriju) to 0.201 (Goian&#x000e9;sia do Par&#x000e1;), and are strongly correlated to the corresponding Annual Parasite Index (API). We detected two sites with distinct characteristics: Goian&#x000e9;sia do Par&#x000e1; where seroprevalence curve does not change with age, and Sucuriju where seroprevalence curve is better described by a model with two SCRs compatible with a decrease in force of infection occurred 14 years ago (from 0.069 to 0.005). For <italic>P. falciparum</italic> antigens, current SCR estimates varied from 0.002 (Bel&#x000e9;m) to 0.018 (Goian&#x000e9;sia do Par&#x000e1;). We also detected a putative decrease in disease transmission occurred &#x0223c;29 years ago in Anaj&#x000e1;s, Goian&#x000e9;sia do Par&#x000e1;, Itaituba, Jacareacanga, and Trair&#x000e3;o.</p></sec><sec><title>Conclusions</title><p>We observed heterogeneity of serological indices across study sites with different endemicity levels and temporal changes in the force of infection in some of the sites. Our study provides further evidence that serology can be used to measure and monitor transmission of both major species of malaria parasite.</p></sec></abstract><funding-group><funding-statement>This work was supported by the CNPq-Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico and FAPESPA-Funda&#x000e7;&#x000e3;o Amaz&#x000f4;nia Paraense de Pesquisa, under the Rede Paraense de Mal&#x000e1;ria, Processo 555654/2009-5, FAPESPA and VALE S.A./ICAAF 070/2011 and FAPESPA/PPSUS/MS/ICAAF 182/2012. MGC acknowledges financial support from CAPES-Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior/studentship/Processo 1240-10-2. NS was supported by Funda&#x000e7;&#x000e3;o para Ciencia e Tecnologia project Pest-OE-MAT-UI0006/2011. CJD and NS are supported by the Wellcome Trust (grant number 091924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="17"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All data are included within the manuscript.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The authors confirm that all data underlying the findings are fully available without restriction. All data are included within the manuscript.</p></notes></front><body><sec id="s1"><title>Introduction</title><p>Efforts in mapping malaria transmission have demonstrated a wider geographical distribution of the parasite <italic>Plasmodium vivax</italic> compared to <italic>P. falciparum</italic>
<xref rid="pone.0113357-Guerra1" ref-type="bibr">[1]</xref>,<xref rid="pone.0113357-Guerra2" ref-type="bibr">[2]</xref>. The number of clinical cases due to <italic>P. vivax</italic> infection has been estimated from 106 to 313 million cases per year across the world <xref rid="pone.0113357-Price1" ref-type="bibr">[3]</xref>. In South America, <italic>P. vivax</italic> is currently the most predominant malaria species <xref rid="pone.0113357-Guerra2" ref-type="bibr">[2]</xref>&#x02013;<xref rid="pone.0113357-World1" ref-type="bibr">[5]</xref> and the Brazilian Amazon region has been considered a natural frontier for malaria transmission since 1970 <xref rid="pone.0113357-Tauil1" ref-type="bibr">[6]</xref>,<xref rid="pone.0113357-OliveiraFerreira1" ref-type="bibr">[7]</xref>, when intense human migration led to a significant increase in the number of malaria cases <xref rid="pone.0113357-BruceChwatt1" ref-type="bibr">[8]</xref>,<xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>. In the last two decades, there were reported between 300,000 to 600,000 malaria cases per year in Brazil with <italic>P. vivax</italic> representing 75&#x02013;80% of these <xref rid="pone.0113357-OliveiraFerreira1" ref-type="bibr">[7]</xref>.</p><p>The control programs have had a significant impact on <italic>P. falciparum</italic> malaria burden in Brazil, which predominated in the past <xref rid="pone.0113357-OliveiraFerreira1" ref-type="bibr">[7]</xref>&#x02013;<xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>, but only a moderate effect on <italic>P. vivax</italic> infections. The high frequency of asymptomatic <italic>P. vivax</italic> carriers in the Brazilian endemic area <xref rid="pone.0113357-Alves1" ref-type="bibr">[10]</xref>&#x02013;<xref rid="pone.0113357-SilvaNunes1" ref-type="bibr">[13]</xref> together with a long period of incubation of hypnozoites <xref rid="pone.0113357-Brasil1" ref-type="bibr">[14]</xref> might be possible explanations for this partial success in controlling this <italic>Plasmodium</italic> species. In this setting of high proportion of asymptomatic carriers, it is critical to have in hand good epidemiological tools in order to assess not only the status quo of disease dynamics, but also to monitor any change in disease transmission due to malaria control interventions.</p><p>In Brazil, variations or changes in malaria transmission have been previously associated with intensive use of land and environmental transformations due to farming, deforestation, or gold mining <xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>,<xref rid="pone.0113357-Camargo1" ref-type="bibr">[15]</xref>&#x02013;<xref rid="pone.0113357-DeOliveira1" ref-type="bibr">[17]</xref>. Additionally, it has been shown that the proportion of asymptomatic infections in native Amazonian population tends to increase with age <xref rid="pone.0113357-LadeiaAndrade1" ref-type="bibr">[12]</xref>,<xref rid="pone.0113357-SilvaNunes1" ref-type="bibr">[13]</xref>. This observation suggests that continuous parasite exposure, even at a low rate, is enough to induce some degree of protective immunity. The combination of these factors implies additional difficulties in assessing the underlying malaria epidemiology of these low transmission and ecologically variable settings.</p><p>A large sero-epidemiological study, conducted at the end of the 1960's showed an association between malaria endemicity and the prevalence of antibodies against <italic>Plasmodium</italic> antigens across different South and Central American countries <xref rid="pone.0113357-Kagan1" ref-type="bibr">[18]</xref>. Later studies using crude or recombinant antigens from <italic>P. falciparum</italic> and/or <italic>P. vivax</italic> have confirmed these findings in Africa <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>&#x02013;<xref rid="pone.0113357-Cook1" ref-type="bibr">[21]</xref>, Asia <xref rid="pone.0113357-Wickramarachchi1" ref-type="bibr">[22]</xref>,<xref rid="pone.0113357-Cook2" ref-type="bibr">[23]</xref> and South America, including Brazil <xref rid="pone.0113357-LadeiaAndrade1" ref-type="bibr">[12]</xref>
<xref rid="pone.0113357-DeCarvalho1" ref-type="bibr">[24]</xref>&#x02013;<xref rid="pone.0113357-Barbedo1" ref-type="bibr">[30]</xref>.</p><p>Estimation of malaria transmission is routinely based on vector and parasite measures. The possibility of relapses in <italic>P. vivax</italic> infected individuals complicates control significantly and makes statistical inferences over parasite prevalence measures more problematic <xref rid="pone.0113357-Guerra2" ref-type="bibr">[2]</xref>,<xref rid="pone.0113357-Sattabongkot1" ref-type="bibr">[31]</xref>. Alternatively, serological markers are useful in areas of low endemicity, where it is likely to be easier to detect relatively long-lasting antibody responses than a low prevalence of symptomatic or asymptomatic infections in the host or the entomologic infection rate <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>
<xref rid="pone.0113357-Corran1" ref-type="bibr">[32]</xref>&#x02013;<xref rid="pone.0113357-Stewart1" ref-type="bibr">[34]</xref>. This approach has been applied to the estimation of <italic>P. falciparum</italic> malaria transmission. However, there is a scarce number of studies aiming to test whether seroprevalence for <italic>P. vivax</italic> antigens can be an equally good epidemiological tool to measure and monitor changes in malaria transmission rates. With this goal, we have conducted a cross sectional study where we determined the antibody prevalence to <italic>P. vivax</italic> and <italic>P. falciparum</italic> for individuals living in areas with varying malaria endemicity levels in Par&#x000e1; state, Brazilian Amazon region.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Study area</title><p>The present study was conducted in six municipalities in Par&#x000e1; state in the northern region of the country (<xref ref-type="fig" rid="pone-0113357-g001">Figure 1</xref>). Geographically, Par&#x000e1; state is one among eight states that constitute the Brazilian Amazon region and, as such, consists of tropical forest with many rivers. This is an area of intense seasonal rainfall with maximum levels between November and April. Malaria endemicity is typically classified as low endemicity and occurs during and immediately after the rainy season with the peak parasite prevalence typically registered between June and November. The municipalities in this study were selected based on the risk of malaria as estimated by the Brazilian office for malaria surveillance and control <xref rid="pone.0113357-National1" ref-type="bibr">[35]</xref>.</p><fig id="pone-0113357-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.g001</object-id><label>Figure 1</label><caption><title>Map of the study area: A. South America, B. Brazil with Par&#x000e1; state in the Amazon region, C. The sampled six municipalities.</title></caption><graphic xlink:href="pone.0113357.g001"/></fig><p>The samples were collected in ten localities within the municipalities considered to be representative of each area. The number varied from one to three localities per municipality. These municipalities and the corresponding localities were: Anaj&#x000e1;s city (central urban area); Jacareacanga (Porto Rico and S&#x000e3;o Jos&#x000e9;); Goian&#x000e9;sia do Par&#x000e1; (Rouxinol, Santa Paula and Ararandeua); Itaituba (S&#x000e3;o Luiz do Tapaj&#x000f3;s); Trair&#x000e3;o (Tr&#x000ea;s Boeiras); and Bel&#x000e9;m city (Cotijuba island). A malaria-free area, Sucuriju village in Amap&#x000e1; state, was also included in the study. The sampling coverage in relation to total residents of each study site was the following: Anaj&#x000e1;s (12.0%), Bel&#x000e9;m (15.4%), Jacareacanga (19.3%), Goian&#x000e9;sia do Par&#x000e1; (29.3%), Itaituba (48.0%), Sucuriju (61.0%), and Trair&#x000e3;o (81.0%). See <xref ref-type="table" rid="pone-0113357-t001">Table 1</xref> for further details.</p><table-wrap id="pone-0113357-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.t001</object-id><label>Table 1</label><caption><title>Baseline characteristics of the study area where all municipalities are in the Par&#x000e1; state with the exception of Sucuriju village (in the Amap&#x000e1; state).</title></caption><alternatives><graphic id="pone-0113357-t001-1" xlink:href="pone.0113357.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Municipality</td><td align="left" rowspan="1" colspan="1">Year of survey</td><td align="left" rowspan="1" colspan="1">API<xref ref-type="table-fn" rid="nt101">a</xref>
</td><td align="left" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">Age in years, median (range)</td><td align="left" rowspan="1" colspan="1">Males, %</td><td align="left" rowspan="1" colspan="1">Previous exposure, %</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Anaj&#x000e1;s</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">953.7 (high)</td><td align="left" rowspan="1" colspan="1">113</td><td align="left" rowspan="1" colspan="1">29 (2&#x02013;98)</td><td align="left" rowspan="1" colspan="1">58.4</td><td align="left" rowspan="1" colspan="1">89.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Jacareacanga</td><td align="left" rowspan="1" colspan="1">2009</td><td align="left" rowspan="1" colspan="1">138.3 (high)</td><td align="left" rowspan="1" colspan="1">172</td><td align="left" rowspan="1" colspan="1">38 (0&#x02013;75)</td><td align="left" rowspan="1" colspan="1">43.0</td><td align="left" rowspan="1" colspan="1">92.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Goian&#x000e9;sia do Par&#x000e1;</td><td align="left" rowspan="1" colspan="1">2010</td><td align="left" rowspan="1" colspan="1">198.7 (high)</td><td align="left" rowspan="1" colspan="1">262</td><td align="left" rowspan="1" colspan="1">34 (3&#x02013;71)</td><td align="left" rowspan="1" colspan="1">45.0</td><td align="left" rowspan="1" colspan="1">88.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Itaituba</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">74.0 (high)</td><td align="left" rowspan="1" colspan="1">183</td><td align="left" rowspan="1" colspan="1">23 (1&#x02013;81)</td><td align="left" rowspan="1" colspan="1">61.2</td><td align="left" rowspan="1" colspan="1">44.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Trair&#x000e3;o</td><td align="left" rowspan="1" colspan="1">2006</td><td align="left" rowspan="1" colspan="1">54.0 (high)</td><td align="left" rowspan="1" colspan="1">204</td><td align="left" rowspan="1" colspan="1">26 (1&#x02013;82)</td><td align="left" rowspan="1" colspan="1">54.9</td><td align="left" rowspan="1" colspan="1">75.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Sucuriju</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">4.3 (low)</td><td align="left" rowspan="1" colspan="1">253</td><td align="left" rowspan="1" colspan="1">19 (2&#x02013;83)</td><td align="left" rowspan="1" colspan="1">50.6</td><td align="left" rowspan="1" colspan="1">5.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Bel&#x000e9;m</td><td align="left" rowspan="1" colspan="1">2007</td><td align="left" rowspan="1" colspan="1">0.5 (low)</td><td align="left" rowspan="1" colspan="1">143</td><td align="left" rowspan="1" colspan="1">24 (1&#x02013;80)</td><td align="left" rowspan="1" colspan="1">49.7</td><td align="left" rowspan="1" colspan="1">26.6</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p>Annual Parasite Index at the year of survey with the respective classification (low or high) as reported by the Brazilian Ministry of Health (<ext-link ext-link-type="uri" xlink:href="http://www.saude.gov.br/sivep_malaria">www.saude.gov.br/sivep_malaria</ext-link>).</p></fn><fn id="nt102"><label/><p>Sucuriju village is usually considered as malaria-free area.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2b"><title>Ethics statement</title><p>This study was carried out in full accordance with all International and Brazilian accepted guidelines as written informed consent was obtained from all participants. The Ethics committee reviewed and approved all the consent procedures. A signed consent form was approved for all adults and provided by parents or guardians for children under 15 years old. For individuals between 16 and 18 years old, the consent procedure was similar to adult participants. This study was approved by the Federal University of Par&#x000e1; (3686/2005) and by the Evandro Chagas Institute (0014/2007 and 0031/2010) Ethics committee.</p></sec><sec id="s2c"><title>Samples and data collection</title><p>One cross-sectional survey was performed in each study site between 2006 and 2010. The total sample size was 1,330 individuals and ranged from 113 (Anaj&#x000e1;s) to 262 (Goian&#x000e9;sia do Par&#x000e1;) with an average sample size of 190 individuals per municipality. According to the malaria surveillance office of the Brazilian Ministry of Health (SIVEP-Malaria, <ext-link ext-link-type="uri" xlink:href="http://portalweb04.saude.gov.br/sivep_malaria">http://portalweb04.saude.gov.br/sivep_malaria</ext-link>) <xref rid="pone.0113357-National1" ref-type="bibr">[35]</xref>, there are 2 areas (Bel&#x000e9;m and Sucuriju village) with low Annual Parasite Index (API, number of malaria cases per year/thousand inhabitants) and other 5 (Anaj&#x000e1;s, Jacareacanga, Goian&#x000e9;sia do Par&#x000e1;, Itaituba, and Trair&#x000e3;o) with high API at the time of survey (<xref ref-type="table" rid="pone-0113357-t001">Table 1</xref>). Each survey was carried out at meeting points well known by the respective community, such as a health office, a school or a residential house conveniently adapted for medical attendance. Individuals attending these facilities for medical appointments during the survey period were included in the sample. The survey period for each locality was one to two weeks, except in the case of Cotijuba island (Bel&#x000e9;m), where the sampling were carried out for three months, one survey per week in each month. The samples were collected in the following municipality time periods: Anaj&#x000e1;s - August 2009, Jacareacanga - February 2009, Goian&#x000e9;sia do Par&#x000e1; - November 2010, Itaituba - March 2007, Trair&#x000e3;o - October 2006, Bel&#x000e9;m - between September and November 2007, Sucuriju village in Amap&#x000e1; state - June 2007. For each participant, baseline characteristics were recorded and comprised information on time living in the sampling area and self-reported history of malaria including the number of previous malaria episodes and corresponding symptoms, and, in the case of having reported malaria during the previous year before survey, whether that was confirmed by thick blood smear.</p><p>Blood samples were taken by finger prick to prepare thick blood smears and collected into microtainer tubes. The tubes were centrifuged at 2000 rpm with the sera subsequently stored at 4&#x000b0;C. The thick blood smear was examined immediately after and parasitaemia assessed by two experienced microscopists where 200 fields were read from each slide before being declared negative <xref rid="pone.0113357-MinistriodaSadeSecretariadeVigilnciaem1" ref-type="bibr">[36]</xref>.</p></sec><sec id="s2d"><title>Serological assays</title><p>All sera were tested for IgG antibodies to recombinant blood-stage <italic>P. vivax</italic> and <italic>P. falciparum</italic> malaria antigens: apical membrane antigen 1 (AMA1) and merozoite surface protein 1 (MSP1) using quantitative enzyme-linked immunosorbent assay (ELISA) as described elsewhere <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>,<xref rid="pone.0113357-Cunha1" ref-type="bibr">[37]</xref>,<xref rid="pone.0113357-Corran2" ref-type="bibr">[38]</xref>. For <italic>P.vivax</italic> two recombinant proteins of MSP1 (Bel&#x000e9;m genotype), both contained the 19 KDa C-terminal portion of MSP1 (MSP1<sub>19</sub>) in fusion with histydine tag (His<sub>6</sub>) or Glutationa S-transferase (GST) <xref rid="pone.0113357-Cunha1" ref-type="bibr">[37]</xref>, as well as AMA1 (Salvador genotype) were used. For <italic>P. falciparum</italic> malaria antigens AMA1 (3D7) and MSP1<sub>19</sub> (Wellcome) <xref rid="pone.0113357-Corran2" ref-type="bibr">[38]</xref>. Briefly, Immunolon-4HBX plates were coated overnight at 4&#x000b0;C at a concentration of 0.5 &#x000b5;g/ml of each recombinant antigen diluted in 50 &#x000b5;l per well. Plates were washed using PBS, 0.05% Tween 20 (PBS/T) and blocked using 1% (w/v) skimmed milk powder in PBS/T. After this step, 50 &#x000b5;l of each sample, a positive control (a pool of hyperimmune serum collected from two malaria endemic area, Gambia and Brazil in case of test with antigen from <italic>P. falciparum</italic> and <italic>P. vivax</italic>, respectively) were added in duplicate to each plate. The sera were tested at a final dilution of 1&#x02236;1000 for both <italic>P. vivax</italic> recombinant proteins, and 1&#x02236;1000 and 1&#x02236;2000 for <italic>P. falciparum</italic> MSP1<sub>19</sub> and AMA1, respectively. The plates were washed and horse-radish peroxidase conjugate rabbit anti-human IgG antibody (DAKO, Roskilde, Denmark) was added to all wells at a dilution 1&#x02236;5000 in PBS/T. Antibody responses were detected after development with o-phenylenediamine dihydrochloride substrate solution (OPD) for 20 minutes. Reactions were stopped with 25 &#x000b5;l per well of 2M H<sub>2</sub>SO<sub>4</sub>. Plates were read immediately at 492 nm on a Molecular Devices Versa Max ELISA reader and optical density (OD) values recorded.</p></sec><sec id="s2e"><title>Statistical analysis</title><p>Duplicate ELISA OD values were averaged and normalized against the positive control sample on each plate. OD data was then converted to antibody titers, expressed in Arbitrary Units (AU/ml), using a standard curve obtained from an appropriate hyperendemic sera control. Antibody titers were calculated using the formula: titer &#x0200a;=&#x0200a; dilution/[maximum OD/(OD test serum &#x02013; minimum OD) -1] (33). Seropositivity was determined by fitting a mixture model to normalised OD values. The model assumed two Gaussian distributions, one for sero-negative individuals and another for sero-positive individuals <xref rid="pone.0113357-Vyse1" ref-type="bibr">[39]</xref>. The mean OD plus three standard deviations associated with the sero-negative group was used as the cut-off value for seropositivity. A separate cut-off was generated for each antigen of each species.</p><p>Seroprevalence was stratified into yearly age groups and then analyzed using a reverse catalytic modeling approach under a binomial sampling assumption, as described elsewhere <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>,<xref rid="pone.0113357-Cook1" ref-type="bibr">[21]</xref>,<xref rid="pone.0113357-Corran2" ref-type="bibr">[38]</xref>,<xref rid="pone.0113357-Vyse1" ref-type="bibr">[39]</xref>. In this context we aimed to estimate two key parameters (i) the seroconversion rate (SCR or &#x003bb;) that is the annual rate at which individuals change from seronegative to seropositive and is related to disease transmission intensity <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>,<xref rid="pone.0113357-Cook1" ref-type="bibr">[21]</xref>,<xref rid="pone.0113357-Corran2" ref-type="bibr">[38]</xref> and (ii) seroreversion rate (SRR or &#x003c1;) that is the annual rate at which seropositive subjects revert to a seronegative state. Each data set was analyzed using two reversible catalytic models, one that assumes a constant-SCR over time and another that assumes a change in SCR at a given time point. The models were estimated by means of maximum likelihood method. In the case of the model assuming a change in SCR, we applied the profile likelihood method to obtain the most likely time point where that change occurred <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref>,<xref rid="pone.0113357-Cook1" ref-type="bibr">[21]</xref>. Where indicated, comparison between these different models was carried out by means of likelihood ratio tests. To obtain confidence intervals and standard errors for SCR and SRR we used bootstrap as follows: (1) re-sample with replacement from the original data, (2) fit the best model to this new data and save the respective estimates, (3) repeat previous steps (e.g., 1000 times) until obtaining a sample of estimates, (4) calculate the standard deviation of the estimates sample associated with each parameter (bootstrap-based standard error) and the 2.5% and 97.5% quantiles (lower and upper bound of the bootstrap-based confidence interval).</p><p>To analyze age-adjusted antibody levels, the highest titer level for antigens to the same <italic>Plasmodium</italic> species was calculated for each individual and then log-transformed in order to obtain Gaussian distributions approximately. The corresponding analysis was carried out using the Michaelis-Menten model as available in the &#x02018;vgam&#x02019; package for the R software <xref rid="pone.0113357-Yee1" ref-type="bibr">[40]</xref>. In the case of <italic>P. falciparum</italic> antibody titers from Jacareacanga, we fitted two Michaelis-Menten curves using the age cut-off obtained from the best catalytic model for the corresponding seroprevalence curve.</p><p>Finally, a correlation analysis between pairs of different site-specific measures (e.g., API versus seroconversion rates) was performed using the non-parametric <italic>Spearman's</italic> correlation coefficient. We also used logistic regression to correlate previous malaria exposure with age adjusting for municipality and gender.</p><p>All statistical analysis was done in the R software (version 3.0, htpp://cran.r-project.org) using our own scripts.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Baseline data reveals regional malaria endemicity variations</title><p>The number of individuals recruited at each site ranged from 113 to 262 (<xref ref-type="table" rid="pone-0113357-t001">Table 1</xref>). The percentage of participants ranged from 12% (Anaj&#x000e1;s) to 81% (Trair&#x000e3;o) of the total residents in each locality. The percentage of individuals reporting previous malaria infections varied widely across sites, ranging from 5% (Sucuriju) to 92.4% (Jacareacanga) (<xref ref-type="table" rid="pone-0113357-t001">Table 1</xref>). Although some differences across sites can be highlighted in the age distribution and male/female proportion, data suggest two clusters of municipalities: one comprising 5 municipalities (Anaj&#x000e1;s, Jacareacanga, Goian&#x000e9;sia do Par&#x000e1;, Itaituba and Trair&#x000e3;o) with higher levels of previous exposure and another including 2 municipalities (Bel&#x000e9;m and Sucuriju) where malaria exposure is low. Previous exposure is highly and positively associated with age (OR&#x0200a;=&#x0200a;1.54 per 10-year increase, CI 95%&#x0200a;=&#x0200a;(1.40;1.68), p-value &#x0003c;10<sup>&#x02212;15</sup>; logistic regression adjusted for gender, age and municipality) and older individuals are more exposed to malaria than younger ones. There was also a strong correlation between the respective Annual Parasite Index (API) as reported by Brazilian Ministry Health and reported malaria exposure (&#x003c1;&#x0200a;=&#x0200a;0.82, Spearman's correlation coefficient, p&#x0200a;=&#x0200a;0.03). Data on previous exposure to malaria would appear to reflect the official statistics of the study area.</p><p>Seroprevalence to any <italic>P. vivax</italic> or <italic>P. falciparum</italic> antigens, or to either <italic>Plasmodium</italic> species, also showed variation between municipalities (<xref ref-type="table" rid="pone-0113357-t002">Table 2</xref>). Seroprevalence for any <italic>P.vivax</italic> antigens ranged from 19.6% (Bel&#x000e9;m) to 77.5% (Goian&#x000e9;sia do Par&#x000e1;), while seroprevalence for any <italic>P. falciparum</italic> antigens is estimated to be between 0.8% (Sucuriju) and 59.3% (Jacareacanga). As expected, seroprevalence to any <italic>P. vivax</italic> antigens was higher than that to any <italic>P. falciparum</italic> ones in every study site. Parasite prevalence was low and ranging from 0 to 5%. Official API was highly correlated to the seroprevalence to any <italic>P. vivax</italic> antigen, but only moderately correlated with that to any <italic>P. falciparum</italic> antigen (&#x003c1;<sub>API- vivax</sub>&#x0200a;=&#x0200a;0.86, p&#x0200a;=&#x0200a;0.02 versus &#x003c1;<sub>API-falciparum</sub>&#x0200a;=&#x0200a;0.64, p&#x0200a;=&#x0200a;0.14, Spearman's correlation coefficient). This likely reflects the difference between the contributions of <italic>P. vivax</italic> and <italic>P. falciparum</italic> to malaria burden, with API representing all malaria cases.</p><table-wrap id="pone-0113357-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.t002</object-id><label>Table 2</label><caption><title>Parasite prevalence using thick blood smear and seroprevalence to any <italic>P. vivax</italic> and <italic>P. falciparum</italic> antigens and to any species.</title></caption><alternatives><graphic id="pone-0113357-t002-2" xlink:href="pone.0113357.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Municipality<xref ref-type="table-fn" rid="nt103">a</xref>
</td><td align="left" rowspan="1" colspan="1">Parasite prevalence, %</td><td colspan="3" align="left" rowspan="1">Seroprevalence, % (95% confidence interval)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<italic>P. vivax</italic>
</td><td align="left" rowspan="1" colspan="1">
<italic>P. falciparum</italic>
</td><td align="left" rowspan="1" colspan="1">Any species</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Anaj&#x000e1;s</td><td align="left" rowspan="1" colspan="1">1.8 (0.2&#x02013;6.2)</td><td align="left" rowspan="1" colspan="1">68.1 (58.7&#x02013;76.6)</td><td align="left" rowspan="1" colspan="1">21.2 (14.1&#x02013;29.9)</td><td align="left" rowspan="1" colspan="1">73.5 (64.3&#x02013;81.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jacareacanga</td><td align="left" rowspan="1" colspan="1">2.3 (0.6&#x02013;5.8)</td><td align="left" rowspan="1" colspan="1">69.2 (61.7&#x02013;76.0)</td><td align="left" rowspan="1" colspan="1">59.3 (51.6&#x02013;66.7)</td><td align="left" rowspan="1" colspan="1">82.0 (75.4&#x02013;87.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Goian&#x000e9;sia do Par&#x000e1;</td><td align="left" rowspan="1" colspan="1">5.0 (2.7&#x02013;8.3)</td><td align="left" rowspan="1" colspan="1">77.5 (71.9&#x02013;82.4)</td><td align="left" rowspan="1" colspan="1">45.8 (39.7&#x02013;52.0)</td><td align="left" rowspan="1" colspan="1">87.8 (83.2&#x02013;91.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Itaituba</td><td align="left" rowspan="1" colspan="1">0.0 (0.0&#x02013;2.0)</td><td align="left" rowspan="1" colspan="1">37.7 (30.7&#x02013;45.2)</td><td align="left" rowspan="1" colspan="1">12.0 (7.7&#x02013;17.6)</td><td align="left" rowspan="1" colspan="1">41.5 (34.3&#x02013;49.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Trair&#x000e3;o</td><td align="left" rowspan="1" colspan="1">1.5 (0.3&#x02013;4.2)</td><td align="left" rowspan="1" colspan="1">64.2 (57.2&#x02013;70.8)</td><td align="left" rowspan="1" colspan="1">27.0 (21.0&#x02013;33.6)</td><td align="left" rowspan="1" colspan="1">68.6 (61.8&#x02013;74.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sucuriju</td><td align="left" rowspan="1" colspan="1">0.0 (0.0&#x02013;1.4)</td><td align="left" rowspan="1" colspan="1">28.1 (22.6&#x02013;34.0)</td><td align="left" rowspan="1" colspan="1">0.8 (0.1&#x02013;2.8)</td><td align="left" rowspan="1" colspan="1">28.9 (23.4&#x02013;34.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bel&#x000e9;m</td><td align="left" rowspan="1" colspan="1">0.0 (0.0&#x02013;2.5)</td><td align="left" rowspan="1" colspan="1">19.6 (13.4&#x02013;27.0)</td><td align="left" rowspan="1" colspan="1">2.8 (0.8&#x02013;7.0)</td><td align="left" rowspan="1" colspan="1">21.0 (14.6&#x02013;28.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">All samples</td><td align="left" rowspan="1" colspan="1">1.7 (1.0&#x02013;2.5)</td><td align="left" rowspan="1" colspan="1">52.5 (49.8&#x02013;55.2)</td><td align="left" rowspan="1" colspan="1">24.7 (22.4&#x02013;27.1)</td><td align="left" rowspan="1" colspan="1">58.1 (55.4&#x02013;60.8)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label>a</label><p>Municipalities sorted by API at the year of the survey as shown in <xref ref-type="table" rid="pone-0113357-t001">Table 1</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Seroconversion rates and antibody levels to any <italic>P. vivax</italic> antigens and characterization of study sites by endemicity level</title><p>Seroconversion rates (SCR) were estimated in different study sites (<xref ref-type="table" rid="pone-0113357-t003">Table 3</xref>). For <italic>P. vivax</italic> seroprevalence, the best model for the data assumes a stable transmission throughout time but with different transmission intensities across sites with the exception of Sucuriju in the Amap&#x000e1; state (<xref ref-type="fig" rid="pone-0113357-g002">Figure 2A</xref>). SCR estimates for disease transmission range from 0.005 (Sucuriju) to 0.201 (Goian&#x000e9;sia do Par&#x000e1;), and are strongly correlated to the corresponding yearly API (r<sub>SCR-API</sub>&#x0200a;=&#x0200a;0.89, Spearman's correlation coefficient) (<xref ref-type="fig" rid="pone-0113357-g002">Figure 2B</xref>). In the case of Sucuriju where malaria endemicity is low according to the Brazilian Ministry Health <xref rid="pone.0113357-National1" ref-type="bibr">[35]</xref>, the data is better described by a model where a 92.8% drop in SCR (from 0.069 to 0.005) appears to have occurred 14 years before our data collection. SCR estimates for <italic>P. vivax</italic> were not correlated with other measures of transmission intensity, such as parasite prevalence (presumably because of the low numbers of individuals who were found to be parasite positive). All positive individuals were infected with <italic>P. vivax</italic>, except for one case in Goian&#x000e9;sia do Par&#x000e1; which was infected with <italic>P. falciparum</italic> (<xref ref-type="table" rid="pone-0113357-t002">Table 2</xref>). There are few entomological inoculation rate (EIR) estimates for <italic>P. vivax</italic> to allow a robust and reliable correlation.</p><fig id="pone-0113357-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.g002</object-id><label>Figure 2</label><caption><title>Statistical analysis of seropositivity data.</title><p>
<bold>A</bold>. Age-adjusted seroprevalence for any <italic>P. vivax</italic> (blue solid lines) or <italic>P. falciparum</italic> antigens (red solid lines) using appropriate reversible catalytic models. The observed seroprevalences for each <italic>Plasmodium</italic> species (blue- and red-filled circles) were pooled according to the 10%-centiles of the underlying age distribution. Note that Sucuriju data for <italic>P. falciparum</italic> were excluded from the analysis due to the small number of sero-positive individuals (two cases only). <bold>B.</bold> Correlation analysis for any <italic>P. vivax</italic> antigens using the annual parasite index versus seroconversion rate.</p></caption><graphic xlink:href="pone.0113357.g002"/></fig><table-wrap id="pone-0113357-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.t003</object-id><label>Table 3</label><caption><title>Statistical analysis of age-adjusted seroprevalence data using reversible catalytic models.</title></caption><alternatives><graphic id="pone-0113357-t003-3" xlink:href="pone.0113357.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Seroprevalence</td><td align="left" rowspan="1" colspan="1">Municipality</td><td align="left" rowspan="1" colspan="1">&#x003bb;<sub>current</sub> (95% CI)</td><td align="left" rowspan="1" colspan="1">&#x003bb;<sub>past</sub> (95% CI)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Any <italic>P. vivax</italic>
</td><td align="left" rowspan="1" colspan="1">Anaj&#x000e1;s</td><td align="left" rowspan="1" colspan="1">0.146 (0.096,0.236)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Jacareacanga</td><td align="left" rowspan="1" colspan="1">0.145 (0.096,0.234)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Goian&#x000e9;sia do Par&#x000e1;</td><td align="left" rowspan="1" colspan="1">0.201 (0.125,0.316)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Itaituba</td><td align="left" rowspan="1" colspan="1">0.050 (0.034,0.072)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Trair&#x000e3;o</td><td align="left" rowspan="1" colspan="1">0.138 (0.092,0.203)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sucuriju</td><td align="left" rowspan="1" colspan="1">0.005 (0.001,0.010)</td><td align="left" rowspan="1" colspan="1">0.069 (0.030,0.220)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Bel&#x000e9;m</td><td align="left" rowspan="1" colspan="1">0.015 (0.009,0.023)</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Any <italic>P. falciparum</italic>
</td><td align="left" rowspan="1" colspan="1">Anaj&#x000e1;s</td><td align="left" rowspan="1" colspan="1">0.008 (0.003,0.013)</td><td align="left" rowspan="1" colspan="1">0.014 (0.001,0.040)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Jacareacanga</td><td align="left" rowspan="1" colspan="1">0.017 (0.009,0.030)</td><td align="left" rowspan="1" colspan="1">0.514 (0.042,26.272)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Goian&#x000e9;sia do Par&#x000e1;</td><td align="left" rowspan="1" colspan="1">0.018 (0.012,0.024)</td><td align="left" rowspan="1" colspan="1">0.047 (0.023,0.075)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Itaituba</td><td align="left" rowspan="1" colspan="1">0.004 (0.001,0.007)</td><td align="left" rowspan="1" colspan="1">0.014 (0.001,0.029)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Trair&#x000e3;o</td><td align="left" rowspan="1" colspan="1">0.011 (0.006,0.017)</td><td align="left" rowspan="1" colspan="1">0.024 (0.005,0.058)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sucuriju</td><td align="left" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Bel&#x000e9;m</td><td align="left" rowspan="1" colspan="1">0.002 (0.000,0.004)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001 (0.000,0.007)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>For <italic>P. vivax</italic> seropositivity data the best model assumes (i) a single seroconversion rate for every site apart from Sucuriju where a changed in seroconversion rate seemed to have occurred 14 years ago and (ii) two seroreversion rates, one for Anaj&#x000e1;s, Jacareacanga, Goian&#x000e9;sia do Par&#x000e1;, Itaituba and Trair&#x000e3;o (&#x003c1;&#x0200a;=&#x0200a;0.054, 95%CI&#x0200a;=&#x0200a;(0.033,0.081)), and another one for Sucuriju and Bel&#x000e9;m (&#x003c1;&#x0200a;=&#x0200a;0.018, 95%CI&#x0200a;=&#x0200a;(0.002,0.039)). For <italic>P. falciparum</italic> data, the best model assumes: (i) a change in force of infection occurred 29 years ago and (ii) a common seroreversion rate for all study sites (&#x003c1;&#x0200a;=&#x0200a;0.007, 95%CI&#x0200a;=&#x0200a;(0.001,0.029)). Data of Sucuriju was not analysed due to a low number of seropositive individuals for any <italic>P. falciparum</italic> antigens.</p></fn></table-wrap-foot></table-wrap><p>Likewise for age-adjusted seroprevalence curves, <italic>P. vivax</italic> antibody titers also increase with age and then reaching a plateau (<xref ref-type="fig" rid="pone-0113357-g003">Figure 3</xref>). Variations were observed for this plateau but these do not exceed one order of magnitude across sites. More importantly, variation seems more easily defined by the speed by which the plateau is reached, thus reflecting the rate of malaria exposure. Overall, the sites seem to be divided into two main clusters in line with those defined earlier based on API (<xref ref-type="supplementary-material" rid="pone.0113357.s001">Figure S1A</xref>). The first one is formed by Anaj&#x000e1;s, Jacareacanga, Goian&#x000e9;sia do Par&#x000e1; and Trair&#x000e3;o, where the <italic>P. vivax</italic> antibody level plateau is achieved at a younger age (&#x0223c;20 years old) due to higher malaria transmission and exposure. In the second cluster - Itaituba, Sucuriju, and Bel&#x000e9;m - the peak antibody level is reached at an older age (&#x0223c;30 years old), reflecting a low malaria exposure. Similar clustering can be observed using age-adjusted seroprevalence curves (<xref ref-type="supplementary-material" rid="pone.0113357.s001">Figure S1B</xref>).</p><fig id="pone-0113357-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113357.g003</object-id><label>Figure 3</label><caption><title>Statistical analysis of antibody titers data.</title><p>Age-adjusted log10-transformed antibody titer profiles for any <italic>P. vivax</italic> (blue solid lines) or <italic>P. falciparum</italic> antigens (red solid lines) using appropriate Michaelis-Menten models. Blue- and red-filled circles represent the observed mean antibody titer after pooling the data according to the 10%-centiles of the underlying age distribution. The antibody levels refer to the maximum among these reacting to AMA1 and the MSP1 antigens.</p></caption><graphic xlink:href="pone.0113357.g003"/></fig></sec><sec id="s3c"><title>Comparison of <italic>P. vivax</italic> and <italic>P. falciparum</italic> serological data</title><p>All <italic>P. falciparum</italic> seroconversion curves were best described by a model assuming a change in disease transmission occurred &#x0223c;29 years before our sampling was conducted (<xref ref-type="table" rid="pone-0113357-t003">Table 3</xref>). Historical SCR (older than 29 years ago) varied between &#x0003c;0.001 (Bel&#x000e9;m) to 0.514 (Jacareacanga) while current SCR range from 0.002 (Bel&#x000e9;m) to 0.018 (Goian&#x000e9;sia do Par&#x000e1;). No model was fitted to Sucuriju data because of its low seroprevalence (two seropositive individuals only, <xref ref-type="table" rid="pone-0113357-t002">Table 2</xref>). Using SCR-EIR relationship established for <italic>P. falciparum</italic> in Africa, these values represent an overall range of EIR of &#x0003e;0.1 infectious bites per person per year (ib/p/yr) to 1 ib/p/yr except in Jacareacanga where the historical SCR (&#x003bb;<sub>1</sub>) suggests an EIR of &#x0003e;20ib/p/yr.</p><p>In line with the seroprevalence data, the age-adjusted antibody profiles are lower in the <italic>P. falciparum</italic> than in <italic>P. vivax</italic> antibody data (<xref ref-type="fig" rid="pone-0113357-g003">Figure 3</xref>). These profiles show little variation at younger ages but a wide range of plateaus older ages (<xref ref-type="supplementary-material" rid="pone.0113357.s001">Figure S1B</xref>). In the case of Jacareacanga, we could detect a change point in the age-adjusted antibody titer curve around 26 years old similar to that of the corresponding seroprevalence curve.</p></sec></sec><sec id="s4"><title>Discussion</title><p>This study reports data on antibodies responses to AMA-1 and MSP1<sub>19</sub> antigens from <italic>P. vivax</italic> and <italic>P. falciparum</italic> in 1,330 individuals living in different malaria transmission areas in the Par&#x000e1; state, Brazil. Specific IgG antibody responses, either as titer or seroprevalence, are in good agreement with government-derived API estimates. For <italic>P. vivax</italic>, the minimum and maximum SCRs were obtained in Bel&#x000e9;m and Goian&#x000e9;sia do Par&#x000e1; with the lowest and the highest number of reported malaria cases, respectively. For each municipality, age-adjusted seroprevalence curves for <italic>P. vivax</italic> antigens were higher than the ones for <italic>P. falciparum</italic> antigens, reflecting that the predominance of infections of that species in the different study sites. In agreement with this observation, antibody titers to <italic>P. vivax</italic> antigens tend to reach their corresponding plateau sooner than its <italic>P. falciparum</italic> counterparts. These data support previous work in areas where these species are co-endemic <xref rid="pone.0113357-Kagan2" ref-type="bibr">[41]</xref>,<xref rid="pone.0113357-Cook3" ref-type="bibr">[42]</xref>, showing that SCR provides a reliable tool for assessing malaria endemicity for both species.</p><p>For the serological analysis of <italic>P. vivax</italic> reponses, age-adjusted seroprevalence curves are best fit by simple catalytic models that assumes a stable SCR throughout time but different estimates for the sites. These differences in SCR estimates are likely to reflect the different ecological factors that affect malaria exposure and the acquisition of immunity to malaria in the area. For example, gold mining is the predominant activity in the riverine Jacareacanga. It was previously shown that mining populations exhibit acquisition of immunity to malaria <xref rid="pone.0113357-Carvalho1" ref-type="bibr">[43]</xref>. Mining can also contribute to an increase in number of mosquito breeding sites due to extensive borrow pits dug along mining sites, mimicking the riverine floodwater impoundments <xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>. The deforestation occurred in Goian&#x000e9;sia do Par&#x000e1; might have been an important factor to the increased malaria risk in the municipality, as observed elsewhere <xref rid="pone.0113357-DeOliveira1" ref-type="bibr">[17]</xref>. The coastal city of Bel&#x000e9;m, as the state capital, is instead more likely to be affected by imported malaria cases due to migration from the surrounding areas. An outlying site is Sucuriju in the Amap&#x000e1; state, where a model assuming distinct disease exposures between younger (&#x0003c;15 years olds) and older individuals (&#x02267;15 years old) provides a better fit to the data. Since this site has had no recorded malaria cases in recent years, possible explanation is a past migratory wave to Sucuriju from other parts of Amap&#x000e1; or from another surrounding state with ongoing malaria transmission. Migration is likely to be age and season specific as reviewed elsewhere <xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>
<xref rid="pone.0113357-Sawyer1" ref-type="bibr">[44]</xref> but the exact nature needs further investigation.</p><p>For <italic>P. falciparum</italic>, data suggests a change in transmission occurred &#x0223c;29 years before our data collection. This estimate for the time of change in transmission is in line with the extensive wave of emigrants from different parts of Brazil to sites surrounding mining activities occurred in 1980s <xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>. As a reaction of migration to mining and farming sites, the Brazilian health authorities initiated several malaria control programs. One of these programs was the SUCAM (Superintendencia de Campanhas de Sa&#x000fa;de P&#x000fa;blica) which, between 1980s and 1990s, used DDT spraying inside dwellings and actively sought and treated of cases using different anti-malarial drugs <xref rid="pone.0113357-Marques1" ref-type="bibr">[9]</xref>. Whilst not wholly successful, the implementation of the program probably had a non-negligible impact on the Amazonian circulating parasite population as shown in a recent retrospective study that suggests the occurrence of bottlenecks on the <italic>P. falciparum</italic> parasite population of Itaituba between the 1980s and 1990s <xref rid="pone.0113357-Griffing1" ref-type="bibr">[45]</xref>. The results further support the potential of this serological approach to describe malaria transmission dynamics in low transmission settings. This has been used for <italic>P. falciparum</italic> before and recently estimated seroconversion rate has been validated with longitudinal data <xref rid="pone.0113357-Arnold1" ref-type="bibr">[46]</xref>. However, data on <italic>P. vivax</italic> are more limited and this is the first time that seroconversion rates have been generated for malaria-exposed populations in the Amazon region.</p><p>There are several potential limitations of this study. The most obvious one concerns the choice and the number of antigens used to evaluate antibody responses. We only used antibodies to two recombinant antigens of each <italic>Plasmodium</italic> species and, therefore, assuming some level of differential immune responsiveness at the individual level, the data might be an under estimate of exposure to infection occurring in the different study sites. Antibodies to other <italic>P. vivax</italic> and <italic>P. falciparum</italic> antigens are available but their role in explaining the natural variation in malaria immunogenicity is still not fully understood. Newer studies have gone some way to identifying antigens or combinations of antigens that may be more robust for this purpose <xref rid="pone.0113357-Lu1" ref-type="bibr">[47]</xref>,<xref rid="pone.0113357-Ondigo1" ref-type="bibr">[48]</xref>.</p><p>Other limitations are related to the timing, type and intensity of the sampling approach. In this study data collection was performed over a 5 year period for the different sites. Whilst the different transmission estimates can be compared and contrasted, temporal comparison between sites reflecting changes in malaria transmission over time or with age is more complicated. However, the profile likelihood approach to estimate changes in transmission identifies a range of years/age over which transmission has changed. In this case, the estimated standard deviations were low and, therefore, broad estimate of 29 years for a change in <italic>P.falciparum</italic> is credible. Perhaps, of more concern for the estimates is the relatively low number of individuals sampled in each site. Besides affecting estimation precision, the small sample size limits the likelihood of identifying statistical significant changes in disease transmission over time from reverse catalytic models. The current sample size has allowed estimates change in transmission for <italic>P.falciparum</italic> that is broadly consistent across sites with plausible biological explanations, however this may not be the case for <italic>P.vivax</italic>. Further, and ideally larger, surveys are required to examine if changes in transmission have occurred for <italic>P.vivax</italic> and, if not, one may ask if this is genuinely more stable transmission perhaps as an immunological consequence of hypnozoite infection. Future surveys will almost certainly require larger sample sizes to demonstrate statistically significant changes in transmission when compared to current surveys (Sep&#x000fa;lveda et al. in preparation). Our surveys were also based on a convenience sampling approach rather than structured community based sample. This could have led to bias in those captured by the survey due to proximity of sampling location and/or health seeking behaviour when the survey was conducted at health facilities. We have previously conducted surveys for serological analysis using communal meeting points <xref rid="pone.0113357-Drakeley1" ref-type="bibr">[19]</xref> and also used health facility attendees <xref rid="pone.0113357-Stewart1" ref-type="bibr">[34]</xref>,<xref rid="pone.0113357-Stresman1" ref-type="bibr">[49]</xref> both approaches providing credible data. In this study for pragmatic reasons, different sampling locations were used at the different sites following recommendations from local contacts. There appears to be no systematic effect of the sampling location on serological data, though we cannot rule this out completely. A standardized approach, such as school surveys <xref rid="pone.0113357-Stevenson1" ref-type="bibr">[50]</xref>, would be much more attractive but these are not always operationally or logistically possible.</p><p>In summary, we have used serological data from anti-malaria antibody responses to can describe areas of different malaria endemicity in Par&#x000e1; state, Brazil. We have demonstrated that seroprevalence data shows good correlation with government-derived API and is able to detect changes in malaria transmission in the study sites.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0113357.s001"><label>Figure S1</label><caption><p>
<bold>Theoretical predictions for the relationship between age, mean antibody titers, and seroprevalance.</bold>
<bold>A</bold>. Expected relationships between age and antibody titers for any <italic>P. vivax</italic> antigens using a Michaelis-Menten modelling approach. <bold>B</bold>. Expected relationships between age and seroprevalence for any <italic>P. vivax</italic> antigens using appropriate reversible catalytic models (see <xref ref-type="table" rid="pone-0113357-t003">Table 3</xref> for the corresponding parameter estimates).</p><p>(TIFF)</p></caption><media xlink:href="pone.0113357.s001.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>Maristela G Cunha acknowledges the CAPES-Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior for scholarship/Processo 1240-10-2. We thank Regina C&#x000e9;lia Guerreiro and Lauro Cunha for the medical attendance of the patients and Hailton Monteiro, Vilson Monteiro, Sandra Oliveira, Rodrigo Marinho and Jos&#x000e9; Mario Veloso for technical assistance during fieldwork.</p></ack><ref-list><title>References</title><ref id="pone.0113357-Guerra1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Guerra</surname><given-names>CA</given-names></name>, <name><surname>Snow</surname><given-names>RW</given-names></name>, <name><surname>Hay</surname><given-names>SI</given-names></name> (<year>2006</year>) <article-title>Mapping the global extent of malaria in 2005</article-title>. <source>Trends Parasitology</source>
<volume>22</volume>:<fpage>353</fpage>&#x02013;<lpage>358</lpage>.</mixed-citation></ref><ref id="pone.0113357-Guerra2"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Guerra</surname><given-names>CA</given-names></name>, <name><surname>Howes</surname><given-names>RE</given-names></name>, <name><surname>Patil</surname><given-names>AP</given-names></name>, <name><surname>Gething</surname><given-names>PW</given-names></name>, <name><surname>Van Boeckel</surname><given-names>TP</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>The international limits and population at risk of <italic>Plasmodium vivax</italic> transmission in 2009</article-title>. <source>PLoS Negleted Tropical Diseases</source>
<volume>4</volume>:<fpage>e774</fpage>.</mixed-citation></ref><ref id="pone.0113357-Price1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Price</surname><given-names>RN</given-names></name>, <name><surname>Tjitra</surname><given-names>E</given-names></name>, <name><surname>Guerra</surname><given-names>CA</given-names></name>, <name><surname>Yeung</surname><given-names>S</given-names></name>, <name><surname>White</surname><given-names>NJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Vivax malaria: neglected and not benign</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>77</volume>:<fpage>79</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">18165478</pub-id></mixed-citation></ref><ref id="pone.0113357-Mueller1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Mueller</surname><given-names>I</given-names></name>, <name><surname>Galinski</surname><given-names>MR</given-names></name>, <name><surname>Baird</surname><given-names>JK</given-names></name>, <name><surname>Carlton</surname><given-names>JM</given-names></name>, <name><surname>Kochar</surname><given-names>DK</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Key gaps in the knowledge of <italic>Plasmodium vivax</italic>, a neglected human malaria parasite</article-title>. <source>The Lancet Infectious Diseases</source>
<volume>9</volume>:<fpage>555</fpage>&#x02013;<lpage>566</lpage>.<pub-id pub-id-type="pmid">19695492</pub-id></mixed-citation></ref><ref id="pone.0113357-World1"><label>5</label><mixed-citation publication-type="other">World Health Organization (2011) Global Malaria Programme: World Malaria report Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/malaria/world_malaria_report_2011/WMR2011_noprofiles_lowres.pdf">http://www.who.int/malaria/world_malaria_report_2011/WMR2011_noprofiles_lowres.pdf</ext-link>.</mixed-citation></ref><ref id="pone.0113357-Tauil1"><label>6</label><mixed-citation publication-type="other">Tauil PL (1986) Comments on the epidemiology and control of malaria in Brazil. Mem&#x000f3;rias do Instituto Oswaldo Cruz 81(Suppl II): 39&#x02013;41.</mixed-citation></ref><ref id="pone.0113357-OliveiraFerreira1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Oliveira-Ferreira</surname><given-names>J</given-names></name>, <name><surname>Lacerda</surname><given-names>MVG</given-names></name>, <name><surname>Brasil</surname><given-names>P</given-names></name>, <name><surname>Ladislau</surname><given-names>JLB</given-names></name>, <name><surname>Tauil</surname><given-names>PL</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Malaria in Brazil: an overview</article-title>. <source>Malaria Journal</source>
<volume>9</volume>:<fpage>115</fpage>.<pub-id pub-id-type="pmid">20433744</pub-id></mixed-citation></ref><ref id="pone.0113357-BruceChwatt1"><label>8</label><mixed-citation publication-type="other">Bruce-Chwatt LJ (1986) Malaria control at the cross-roads! Where do we go from here? Mem&#x000f3;rias do Instituto Oswaldo Cruz 81(Suppl II): 1&#x02013;4.</mixed-citation></ref><ref id="pone.0113357-Marques1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Marques</surname><given-names>AC</given-names></name> (<year>1987</year>) <article-title>Human migration and the spread of malaria in Brazil</article-title>. <source>Parasitology Today</source>
<volume>3</volume>:<fpage>166</fpage>&#x02013;<lpage>170</lpage>.<pub-id pub-id-type="pmid">15462945</pub-id></mixed-citation></ref><ref id="pone.0113357-Alves1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Alves</surname><given-names>FP</given-names></name>, <name><surname>Durlacher</surname><given-names>RR</given-names></name>, <name><surname>Menezes</surname><given-names>MJ</given-names></name>, <name><surname>Kriger</surname><given-names>H</given-names></name>, <name><surname>Silva</surname><given-names>LHP</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>High prevalence of asymptomatic <italic>Plasmodium vivax</italic> and <italic>Plasmodium falciparum</italic> infections in native amazonian populations</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>66</volume>:<fpage>641</fpage>&#x02013;<lpage>648</lpage>.<pub-id pub-id-type="pmid">12224567</pub-id></mixed-citation></ref><ref id="pone.0113357-Coura1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Coura</surname><given-names>JR</given-names></name>, <name><surname>Suarez-Mutis</surname><given-names>M</given-names></name>, <name><surname>Ladeia-Andrade</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>A new challenge for malaria control in Brazil: asymptomatic <italic>Plasmodium</italic> infection &#x02013; a review</article-title>. <source>Mem&#x000f3;rias do Instituto Oswaldo Cruz</source>
<volume>101</volume>:<fpage>229</fpage>&#x02013;<lpage>237</lpage>.<pub-id pub-id-type="pmid">16862314</pub-id></mixed-citation></ref><ref id="pone.0113357-LadeiaAndrade1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Ladeia-Andrade</surname><given-names>S</given-names></name>, <name><surname>Ferreira</surname><given-names>MU</given-names></name>, <name><surname>De Carvalho</surname><given-names>ME</given-names></name>, <name><surname>Curado</surname><given-names>I</given-names></name>, <name><surname>Coura</surname><given-names>JR</given-names></name> (<year>2009</year>) <article-title>Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>80</volume>:<fpage>452</fpage>&#x02013;<lpage>459</lpage>.<pub-id pub-id-type="pmid">19270298</pub-id></mixed-citation></ref><ref id="pone.0113357-SilvaNunes1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Silva-Nunes</surname><given-names>M</given-names></name>, <name><surname>Moreno</surname><given-names>M</given-names></name>, <name><surname>Conn</surname><given-names>JE</given-names></name>, <name><surname>Gamboa</surname><given-names>D</given-names></name>, <name><surname>Abeles</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Amazonian malaria: Asymptomatic human reservoirs, diagnostic chanllenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies</article-title>. <source>Acta Tropica</source>
<volume>121</volume>:<fpage>281</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">22015425</pub-id></mixed-citation></ref><ref id="pone.0113357-Brasil1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Brasil</surname><given-names>P</given-names></name>, <name><surname>Costa</surname><given-names>AP</given-names></name>, <name><surname>Pedro</surname><given-names>RS</given-names></name>, <name><surname>Bressan</surname><given-names>CS</given-names></name>, <name><surname>Silva</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Unexpectedly long incubation period of <italic>Plasmodium vivax</italic> malaria, in the absence of chemoprophylaxis, in patients diagnosed outside the transmission area in Brazil</article-title>. <source>Malaria Journal</source>
<volume>10</volume>:<fpage>122</fpage>.<pub-id pub-id-type="pmid">21569554</pub-id></mixed-citation></ref><ref id="pone.0113357-Camargo1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Camargo</surname><given-names>LMA</given-names></name>, <name><surname>Ferreira</surname><given-names>MU</given-names></name>, <name><surname>Krieger</surname><given-names>H</given-names></name>, <name><surname>Camargo</surname><given-names>EP</given-names></name>, <name><surname>Silva</surname><given-names>LHP</given-names></name> (<year>1994</year>) <article-title>Unstable Hypoendemic malaria in Rondonia (Western Amazon Region, Brazil): epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>51</volume>:<fpage>16</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">8059911</pub-id></mixed-citation></ref><ref id="pone.0113357-SilvaNunes2"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Silva-Nunes</surname><given-names>M</given-names></name>, <name><surname>Code&#x000e7;o</surname><given-names>CT</given-names></name>, <name><surname>Malafronte</surname><given-names>RS</given-names></name>, <name><surname>Silva</surname><given-names>NS</given-names></name>, <name><surname>Juncasen</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Malaria on the Amazonian frontier: transmission dynamics, risk factors, spatial distribution, and prospects for control</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>79</volume>:<fpage>624</fpage>&#x02013;<lpage>635</lpage>.<pub-id pub-id-type="pmid">18840755</pub-id></mixed-citation></ref><ref id="pone.0113357-DeOliveira1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>De Oliveira</surname><given-names>EC</given-names></name>, <name><surname>Santos</surname><given-names>ES</given-names></name>, <name><surname>Zeilhofer</surname><given-names>P</given-names></name>, <name><surname>Souza-Santos</surname><given-names>R</given-names></name>, <name><surname>Atanaka-Santo</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Spatial patterns of malaria in a land reform colonization project, Juruena municipality, Mato Grosso, Brazil</article-title>. <source>Malaria Journal</source>
<volume>10</volume>:<fpage>177</fpage>.<pub-id pub-id-type="pmid">21703018</pub-id></mixed-citation></ref><ref id="pone.0113357-Kagan1"><label>18</label><mixed-citation publication-type="other">Kagan IG, Sulzer AJ (1969) The serology of malaria recent applications. World Health Organization, WHO/MAL/69.694, 1&#x02013;12.</mixed-citation></ref><ref id="pone.0113357-Drakeley1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Drakeley</surname><given-names>CJ</given-names></name>, <name><surname>Corran</surname><given-names>PH</given-names></name>, <name><surname>Coleman</surname><given-names>PG</given-names></name>, <name><surname>Tongren</surname><given-names>JE</given-names></name>, <name><surname>McDonald</surname><given-names>SLR</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Estimating medium- and long- term trends in malaria transmission by using serological markers of malaria exposure</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>
<volume>102</volume>:<fpage>5108</fpage>&#x02013;<lpage>5113</lpage>.<pub-id pub-id-type="pmid">15792998</pub-id></mixed-citation></ref><ref id="pone.0113357-Akpogheneta1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Akpogheneta</surname><given-names>OJ</given-names></name>, <name><surname>Dunyo</surname><given-names>S</given-names></name>, <name><surname>Pinder</surname><given-names>M</given-names></name>, <name><surname>Conway</surname><given-names>DJ</given-names></name> (<year>2010</year>) <article-title>Boosting antibody responses to <italic>Plasmodium falciparum</italic> merozoite antigens in children with highly seasonal exposure to infection</article-title>. <source>Parasite Immunology</source>
<volume>32</volume>:<fpage>296</fpage>&#x02013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">20398230</pub-id></mixed-citation></ref><ref id="pone.0113357-Cook1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Kleinschmidt</surname><given-names>I</given-names></name>, <name><surname>Schwabe</surname><given-names>C</given-names></name>, <name><surname>Nseng</surname><given-names>G</given-names></name>, <name><surname>Bousema</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, Equatorial Guinea</article-title>. <source>PLoS ONE</source>
<volume>6</volume>:<fpage>e25137</fpage>.<pub-id pub-id-type="pmid">21980386</pub-id></mixed-citation></ref><ref id="pone.0113357-Wickramarachchi1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Wickramarachchi</surname><given-names>T</given-names></name>, <name><surname>Premaratne</surname><given-names>PH</given-names></name>, <name><surname>Lakshman Perera</surname><given-names>KLR</given-names></name>, <name><surname>Bandara</surname><given-names>S</given-names></name>, <name><surname>Kocken</surname><given-names>CHM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Natural human antibody responses to <italic>Plasmodium vivax</italic> apical membrane antigen 1 under low transmission and unstable malaria conditions in Sri Lanka</article-title>. <source>Infection and Immunity</source>
<volume>74</volume>:<fpage>798</fpage>&#x02013;<lpage>801</lpage>.<pub-id pub-id-type="pmid">16369044</pub-id></mixed-citation></ref><ref id="pone.0113357-Cook2"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Speybroeck</surname><given-names>N</given-names></name>, <name><surname>Sochanta</surname><given-names>T</given-names></name>, <name><surname>Somony</surname><given-names>H</given-names></name>, <name><surname>Sokny</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Sero-epidemiological evaluation of changes in <italic>Plasmodium falciparum</italic> and <italic>Plasmodium vivax</italic> transmission patterns over the rainy season in Cambodia</article-title>. <source>Malaria Journal</source>
<volume>11</volume>:<fpage>86</fpage>.<pub-id pub-id-type="pmid">22443375</pub-id></mixed-citation></ref><ref id="pone.0113357-DeCarvalho1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>De Carvalho</surname><given-names>ME</given-names></name>, <name><surname>Ferreira</surname><given-names>MU</given-names></name>, <name><surname>De Souza</surname><given-names>MRD</given-names></name>, <name><surname>Ninomia</surname><given-names>RT</given-names></name>, <name><surname>Matos</surname><given-names>GF</given-names></name>, <etal>et al</etal> (<year>1992</year>) <article-title>Malaria seroepidemiology: comparison between indirect fluorescent antibody test and enzyme immunoassay using blood spot eluates</article-title>. <source>Mem&#x000f3;rias do Instituto Oswaldo Cruz</source>
<volume>87</volume>:<fpage>205</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="pmid">1308565</pub-id></mixed-citation></ref><ref id="pone.0113357-Soares1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Soares</surname><given-names>IS</given-names></name>, <name><surname>Levitus</surname><given-names>G</given-names></name>, <name><surname>Souza</surname><given-names>JM</given-names></name>, <name><surname>Del Portillo</surname><given-names>HA</given-names></name>, <name><surname>Rodrigues</surname><given-names>MM</given-names></name> (<year>1997</year>) <article-title>Acquired immune response to the N- and C-terminal regions of <italic>Plasmodium vivax</italic> merozoite surface protein 1 in individuals exposed to malaria</article-title>. <source>Infection and Immunity</source>
<volume>65</volume>:<fpage>1606</fpage>&#x02013;<lpage>1614</lpage>.<pub-id pub-id-type="pmid">9125537</pub-id></mixed-citation></ref><ref id="pone.0113357-Soares2"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Soares</surname><given-names>IS</given-names></name>, <name><surname>Oliveira</surname><given-names>S</given-names></name>, <name><surname>Souza</surname><given-names>JM</given-names></name>, <name><surname>Rodrigues</surname><given-names>MM</given-names></name> (<year>1999</year>) <article-title>Antibody response to the N and C-terminal regions of the <italic>Plasmodium vivax</italic> merozoite surface protein 1 in individuals living in an area of exclusive transmission of <italic>P. vivax</italic> in the noth of Brazil</article-title>. <source>Acta Tropica</source>
<volume>72</volume>:<fpage>13</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">9924957</pub-id></mixed-citation></ref><ref id="pone.0113357-Soares3"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Soares</surname><given-names>IS</given-names></name>, <name><surname>Cunha</surname><given-names>MG</given-names></name>, <name><surname>Silva</surname><given-names>MN</given-names></name>, <name><surname>Souza</surname><given-names>JM</given-names></name>, <name><surname>Del Portillo</surname><given-names>HA</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Longevity of naturaly acquired antibody response to the N- and C- terminal regions of <italic>Plasmodium vivax</italic> merozoite surface protein 1</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>60</volume>:<fpage>357</fpage>&#x02013;<lpage>363</lpage>.<pub-id pub-id-type="pmid">10466961</pub-id></mixed-citation></ref><ref id="pone.0113357-Morais1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Morais</surname><given-names>CG</given-names></name>, <name><surname>Soares</surname><given-names>IS</given-names></name>, <name><surname>Carvalho</surname><given-names>LH</given-names></name>, <name><surname>Fontes</surname><given-names>CJ</given-names></name>, <name><surname>Krettli</surname><given-names>AU</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>IgG isotype to C-terminal 19 kDa of <italic>Plasmodium vivax</italic> merozoite surface protein 1 among subjects with different levels of exposure to malaria in Brazil</article-title>. <source>Parasitology Research</source>
<volume>95</volume>:<fpage>420</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">15759156</pub-id></mixed-citation></ref><ref id="pone.0113357-Morais2"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Morais</surname><given-names>CG</given-names></name>, <name><surname>Soares</surname><given-names>IS</given-names></name>, <name><surname>Carvalho</surname><given-names>LH</given-names></name>, <name><surname>Fontes</surname><given-names>CJF</given-names></name>, <name><surname>Krettli</surname><given-names>AU</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Antibodies to <italic>Plasmodium vivax</italic> apical membrane antigen 1: persistence and correlation with malaria transmission intensity</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>75</volume>:<fpage>582</fpage>&#x02013;<lpage>587</lpage>.<pub-id pub-id-type="pmid">17038677</pub-id></mixed-citation></ref><ref id="pone.0113357-Barbedo1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Barbedo</surname><given-names>MB</given-names></name>, <name><surname>Ricci</surname><given-names>R</given-names></name>, <name><surname>Jimenez</surname><given-names>MCS</given-names></name>, <name><surname>Cunha</surname><given-names>MG</given-names></name>, <name><surname>Yazdani</surname><given-names>SS</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Comparative recognition by human IgG antibodies of recombinant proteins representing three asexual erythrocytic stage vaccine candidates of <italic>Plasmodium vivax</italic>
</article-title>. <source>Mem&#x000f3;rias do Instituto Oswaldo Cruz</source>
<volume>102</volume>:<fpage>335</fpage>&#x02013;<lpage>339</lpage>.<pub-id pub-id-type="pmid">17568939</pub-id></mixed-citation></ref><ref id="pone.0113357-Sattabongkot1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Sattabongkot</surname><given-names>J</given-names></name>, <name><surname>Tsuboi</surname><given-names>T</given-names></name>, <name><surname>Zollner</surname><given-names>GE</given-names></name>, <name><surname>Sirichaisinthop</surname><given-names>J</given-names></name>, <name><surname>Cui</surname><given-names>L</given-names></name> (<year>2004</year>) <article-title>
<italic>Plasmodium vivax</italic> transmission: chances for control?</article-title>
<source>Trends in Parasitology</source>
<volume>20</volume>:<fpage>192</fpage>&#x02013;<lpage>198</lpage>.<pub-id pub-id-type="pmid">15099559</pub-id></mixed-citation></ref><ref id="pone.0113357-Corran1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Corran</surname><given-names>P</given-names></name>, <name><surname>Coleman</surname><given-names>P</given-names></name>, <name><surname>Riley</surname><given-names>E</given-names></name>, <name><surname>Drakeley</surname><given-names>C</given-names></name> (<year>2007</year>) <article-title>Serology: a robust indicator of malaria transmission intensity?</article-title>
<source>Trends in Parasitology</source>
<volume>23</volume>:<fpage>575</fpage>&#x02013;<lpage>582</lpage>.<pub-id pub-id-type="pmid">17988945</pub-id></mixed-citation></ref><ref id="pone.0113357-Bousema1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Bousema</surname><given-names>T</given-names></name>, <name><surname>Youssef</surname><given-names>RM</given-names></name>, <name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Cox</surname><given-names>J</given-names></name>, <name><surname>Alegana</surname><given-names>VA</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008</article-title>. <source>Emerging Infectious Disease</source>
<volume>16</volume>:<fpage>392</fpage>&#x02013;<lpage>399</lpage>.</mixed-citation></ref><ref id="pone.0113357-Stewart1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Stewart</surname><given-names>L</given-names></name>, <name><surname>Gosling</surname><given-names>R</given-names></name>, <name><surname>Griffin</surname><given-names>J</given-names></name>, <name><surname>Gesase</surname><given-names>S</given-names></name>, <name><surname>Campo</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Rapid assessment of malaria transmission using age-specific sero-conversion rates</article-title>. <source>PLoS ONE</source>
<volume>4(6)</volume>:<fpage>e6083</fpage>.<pub-id pub-id-type="pmid">19562032</pub-id></mixed-citation></ref><ref id="pone.0113357-National1"><label>35</label><mixed-citation publication-type="other">National program for malaria prevention and control, ministry of health of Brazil. Available: <ext-link ext-link-type="uri" xlink:href="http://portal.saude.gov.br/portal/saude">http://portal.saude.gov.br/portal/saude</ext-link> and SIVEP-Malaria, Available: <ext-link ext-link-type="uri" xlink:href="http://portalweb04.saude.gov.br/sivep_malaria">http://portalweb04.saude.gov.br/sivep_malaria</ext-link>.</mixed-citation></ref><ref id="pone.0113357-MinistriodaSadeSecretariadeVigilnciaem1"><label>36</label><mixed-citation publication-type="other">Minist&#x000e9;rio da Sa&#x000fa;de. Secretaria de Vigil&#x000e2;ncia em Sa&#x000fa;de (2009) Manual de Diagn&#x000f3;stico Laboratorial da Mal&#x000e1;ria, Bras&#x000ed;lia, DF, Brasil.</mixed-citation></ref><ref id="pone.0113357-Cunha1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Cunha</surname><given-names>MG</given-names></name>, <name><surname>Rodrigues</surname><given-names>MM</given-names></name>, <name><surname>Soares</surname><given-names>IS</given-names></name> (<year>2001</year>) <article-title>Comparison of the immunogenic properties of recombinant proteins representing the <italic>Plasmodium vivax</italic> vaccine candidate MSP1<sub>19</sub> expressed in distinct bacterial vectors</article-title>. <source>Vaccine</source>
<volume>20</volume>:<fpage>385</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">11672901</pub-id></mixed-citation></ref><ref id="pone.0113357-Corran2"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Corran</surname><given-names>PH</given-names></name>, <name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Lynch</surname><given-names>C</given-names></name>, <name><surname>Leendertse</surname><given-names>H</given-names></name>, <name><surname>Manjurano</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Dried blood spots as a source of anti-malarial antibodies for epidemiological studies</article-title>. <source>Malaria Journal</source>
<volume>7</volume>:<fpage>195</fpage>.<pub-id pub-id-type="pmid">18826573</pub-id></mixed-citation></ref><ref id="pone.0113357-Vyse1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Vyse</surname><given-names>AJ</given-names></name>, <name><surname>Gay</surname><given-names>NJ</given-names></name>, <name><surname>Hesketh</surname><given-names>LM</given-names></name>, <name><surname>Pebody</surname><given-names>R</given-names></name>, <name><surname>Moran-Capner</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century</article-title>. <source>Epidemiology and Infection</source>
<volume>134</volume>:<fpage>1303</fpage>&#x02013;<lpage>1312</lpage>.<pub-id pub-id-type="pmid">16650326</pub-id></mixed-citation></ref><ref id="pone.0113357-Yee1"><label>40</label><mixed-citation publication-type="other">Yee TW (2010). The VGAM package for categorical data analysis. Journal of Statistical Software 32, 1&#x02013;34.</mixed-citation></ref><ref id="pone.0113357-Kagan2"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Kagan</surname><given-names>IG</given-names></name>, <name><surname>Cahill</surname><given-names>KM</given-names></name> (<year>1968</year>) <article-title>Parasitic serologic studies in Somaliland</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>17</volume>:<fpage>392</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">4297404</pub-id></mixed-citation></ref><ref id="pone.0113357-Cook3"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Reid</surname><given-names>H</given-names></name>, <name><surname>Lavro</surname><given-names>J</given-names></name>, <name><surname>Kuwahata</surname><given-names>M</given-names></name>, <name><surname>Taleo</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Using serological measures to monitor changes in malaria transmission in Vanatu</article-title>. <source>Malaria Journal</source>
<volume>9</volume>:<fpage>169</fpage>.<pub-id pub-id-type="pmid">20553604</pub-id></mixed-citation></ref><ref id="pone.0113357-Carvalho1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Carvalho</surname><given-names>LH</given-names></name>, <name><surname>Fontes</surname><given-names>CJ</given-names></name>, <name><surname>Krettli</surname><given-names>AU</given-names></name> (<year>1999</year>) <article-title>Cellular responses to <italic>Plasmodium falciparum</italic> major surface antigens and their relationship to human activities associated with malaria transmission</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>60</volume>:<fpage>674</fpage>&#x02013;<lpage>679</lpage>.<pub-id pub-id-type="pmid">10348247</pub-id></mixed-citation></ref><ref id="pone.0113357-Sawyer1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Sawyer</surname><given-names>D</given-names></name> (<year>1993</year>) <article-title>Economic and social consequences of malaria in new colonization projects in Brazil</article-title>. <source>Social Science &#x00026; Medicine</source>
<volume>37</volume>:<fpage>1131</fpage>&#x02013;<lpage>1136</lpage>.<pub-id pub-id-type="pmid">8235752</pub-id></mixed-citation></ref><ref id="pone.0113357-Griffing1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Griffing</surname><given-names>SM</given-names></name>, <name><surname>Viana</surname><given-names>GM</given-names></name>, <name><surname>Mixson-Hayden</surname><given-names>T</given-names></name>, <name><surname>Sridaran</surname><given-names>S</given-names></name>, <name><surname>Alam</surname><given-names>MT</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Historical shifts in Brazilian <italic>P. falciparum</italic> population structure and drug resistance alleles</article-title>. <source>PLoS ONE</source>
<volume>8</volume>:<fpage>e58984</fpage>.<pub-id pub-id-type="pmid">23554964</pub-id></mixed-citation></ref><ref id="pone.0113357-Arnold1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Arnold</surname><given-names>BF</given-names></name>, <name><surname>Priest</surname><given-names>JW</given-names></name>, <name><surname>Hamlin</surname><given-names>KL</given-names></name>, <name><surname>Moss</surname><given-names>DM</given-names></name>, <name><surname>Colford</surname><given-names>JM</given-names><suffix>Jr</suffix></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Serological measures of malaria transmission in Haiti: comparison of longitudinal and cross-sectional methods</article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e93684</fpage>.<pub-id pub-id-type="pmid">24691467</pub-id></mixed-citation></ref><ref id="pone.0113357-Lu1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Lu</surname><given-names>F</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Cheng</surname><given-names>Y</given-names></name>, <name><surname>Kong</surname><given-names>DH</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Profiling the humoral immune responses to <italic>Plasmodium vivax</italic> infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA)</article-title>. <source>Journal of Proteomics</source>
<volume>102</volume>:<fpage>66</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">24607491</pub-id></mixed-citation></ref><ref id="pone.0113357-Ondigo1"><label>48</label><mixed-citation publication-type="other">Ondigo BN, Hodges JS, Ireland KF, Magak NG, Lanar DE, <etal>et al</etal><bold>.</bold> (2014) Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple <italic>Plasmodium falciparum</italic> antigens. Journal of Infectious Diseases 8.</mixed-citation></ref><ref id="pone.0113357-Stresman1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Stresman</surname><given-names>GH</given-names></name>, <name><surname>Stevenson</surname><given-names>JC</given-names></name>, <name><surname>Owaga</surname><given-names>C</given-names></name>, <name><surname>Marube</surname><given-names>E</given-names></name>, <name><surname>Anyango</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Validation of three geolocation strategies for health-facility attendees for research and public health surveillance in a rural setting in western Kenya</article-title>. <source>Epidemiology and Infection</source>
<volume>142</volume>:<fpage>1978</fpage>&#x02013;<lpage>1989</lpage>.<pub-id pub-id-type="pmid">24787145</pub-id></mixed-citation></ref><ref id="pone.0113357-Stevenson1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Stevenson</surname><given-names>JC</given-names></name>, <name><surname>Stresman</surname><given-names>GH</given-names></name>, <name><surname>Gitonga</surname><given-names>CW</given-names></name>, <name><surname>Gilling</surname><given-names>J</given-names></name>, <name><surname>Owaga</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan Highlands</article-title>. <source>PloS ONE</source>
<volume>8</volume>:<fpage>e77641</fpage>.<pub-id pub-id-type="pmid">24143250</pub-id></mixed-citation></ref></ref-list></back></article>
